检索结果 - Lisa D. Laury‐Kleintop
- Showing 1 - 7 results of 7
-
1
-
2
Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound <scp>d</scp>-1-Methyl-Tryptophan 由 Richard Metz, James B. DuHadaway, Uma Kamasani, Lisa D. Laury‐Kleintop, Alexander J. Muller, George C. Prendergast
出版 2007Artigo -
3
-
4
-
5
The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells 由 Sara Trabanelli, Darina Očadlíková, Marilena Ciciarello, Valentina Salvestrini, Mariangela Lecciso, Camilla Jandus, Richard Metz, Cecilia Evangelisti, Lisa D. Laury‐Kleintop, Pedro Romero, George C. Prendergast, Antonio Curti, Roberto M. Lemoli
出版 2014Artigo -
6
Reduction of the expression of the late-onset Alzheimer’s disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model 由 Robert J. Andrew, Pierre De Rossi, Phuong Nguyen, Haley R. Kowalski, Aleksandra J. Recupero, Thomas Guerbette, Sofia V. Krause, Richard C. Rice, Lisa D. Laury‐Kleintop, Steven L. Wagner, Gopal Thinakaran
出版 2019Artigo -
7
IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development 由 Courtney Smith, Mee Young Chang, Katherine H. Parker, Daniel W. Beury, James B. DuHadaway, Hollie E. Flick, Janette Boulden, Erika Sutanto‐Ward, Alejandro Peralta Soler, Lisa D. Laury‐Kleintop, Laura Mandik‐Nayak, Richard Metz, Suzanne Ostrand‐Rosenberg, George C. Prendergast, Alexander J. Muller
出版 2012Artigo
相关主题
Biology
Immunology
Biochemistry
Immune system
Medicine
Amino acid
Cancer research
Indoleamine 2,3-dioxygenase
Tryptophan
Cancer
Cell biology
Internal medicine
Catabolism
Cell
Enzyme
Immune tolerance
Immunotherapy
Inflammation
Pathology
Signal transduction
Alzheimer's disease
Amyloid precursor protein
Antibody
Arthritis
Autoantibody
Autoimmune disease
BACE1-AS
Cancer immunotherapy
Carcinogenesis
Cytokine